Diabetes, cancer still top areas for innovation: U.S. pharmaceuticals patent landscape report
Our analysis of the U.S. pharmaceutical patent landscape in 2023 reveals that diseases like diabetes, respiratory conditions, and cancer remain at the forefront innovation. These diseases align closely with the leading causes of death reported by The US Centers for Disease Control and Prevention in 2021. Our report on the U.S. Pharmaceuticals Patent Landscape resulted […]
